Recent Updates
Recently added Catalysts
PEN Positive Sentiment

Penumbra, Inc. to Present at Upcoming Investor Conferences

Key Takeaway: Penumbra, Inc. has announced its participation in two upcoming investor conferences: the Wells Fargo Healthcare Conference on September 3, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025. The presentations will be accessible via webcasts on the company's website for at least two weeks after each event. Penumbra is known for its advancements in thrombectomy technologies.
Price reaction · baseline $255.72 (2025-08-20 close) · hit after-hours · clean, no other PEN news in the window
day 0 close · peak
-1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Penumbra is presenting at notable investor conferences.
  • The company is recognized as a leader in thrombectomy technology.
  • Innovative technologies are being developed for serious medical conditions.

Full Press Release Details

ALAMEDA, Calif., Aug. 20, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times listed below.
Event: 2025 Wells Fargo Healthcare Conference
Date: Wednesday, September 3, 2025
Time: 8:45am ET/5:45am PT
Event: Morgan Stanley 23rd Annual Global Healthcare Conference
Date: Tuesday, September 9, 2025
Time: 1:50pm ET/10:50am PT
Webcasts of the presentations can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcasts will be available on the company's website for at least two weeks following each event.
About Penumbra Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations Penumbra, Inc. investors@penumbrainc.com

Frequently Asked Questions

When is Penumbra presenting at the Wells Fargo Conference?

Penumbra will present at the Wells Fargo Healthcare Conference on September 3, 2025.

What time is the Morgan Stanley Conference presentation?

The Morgan Stanley 23rd Annual Global Healthcare Conference presentation is at 1:50pm ET on September 9, 2025.

Where can I access the conference webcasts?

Webcasts of the presentations will be available on Penumbra's website under the 'Events and Presentations' section.

What technologies does Penumbra focus on?

Penumbra focuses on innovative thrombectomy technologies for conditions like ischemic stroke and venous thromboembolism.

Last updated: Aug 20, 2025